Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethnic differences in drug metabolism.

W Kalow

    Clinical Pharmacokinetics
    |September 1, 1982
    PubMed
    Summary

    Interethnic differences in drug metabolism vary significantly, influenced by both genetics and environment. Studies using probe drugs highlight these variations, impacting how we understand drug efficacy across diverse populations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.

    The pharmacogenomics journal·2006
    Same author

    A simple test for acetylator phenotype using caffeine. 1984.

    British journal of clinical pharmacology·2004
    Same author

    Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicators.

    The pharmacogenomics journal·2002
    Same author

    Multigenic traits and risk assessment in pharmacology: a population approach.

    The pharmacogenomics journal·2002
    Same author

    Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

    Journal of clinical psychopharmacology·2002
    Same author

    Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine.

    European journal of clinical pharmacology·2001

    Area of Science:

    • Pharmacogenomics
    • Drug Metabolism
    • Population Studies

    Background:

    • Substantial interethnic differences exist in drug-metabolizing capacity.
    • These variations can stem from differing mean trait values or genetic enzyme variants within populations.
    • Investigating these differences necessitates large-scale population studies.

    Purpose of the Study:

    • To explore interethnic variations in drug-metabolizing enzymes.
    • To adapt pharmacokinetic methods for population-level drug metabolism studies.
    • To investigate the interplay of genetic and environmental factors in drug metabolism.

    Main Methods:

    • Utilizing probe drugs to assess drug metabolism in different populations.
    • Analyzing pharmacokinetic parameters and specific drug metabolites.
    • Comparing drug-metabolizing enzyme activity across diverse ethnic groups.

    Main Results:

    • Antipyrine data suggest environmental factors are key determinants of metabolic capacity differences.
    • Debrisoquine data indicate monogenic control over certain cytochrome P-450 system variations.
    • Many studies show statistically significant mean differences but lack sample size for genetic polymorphism recognition.

    Conclusions:

    • Drug metabolism varies significantly between ethnic groups, influenced by both genetic and environmental factors.
    • Methodological advancements are needed for accurate population-based pharmacokinetic studies.
    • Understanding these interethnic differences is crucial for personalized medicine and drug development.

    Related Experiment Videos